Your Source for BioScience Venture Capital Data
  • OnBioVC NEWS:

    - OnBioVC Announces Beta Launch of Service
    - OnBioVC INDEX(TM) Updated thru DEC 2009
    - OnBioVC 2009 Year-in-Review, now available
    - OnBioVC 1Q10 Trend Analysis, coming soon
  • SEARCH THE OnBioVC DATABASE:

  • business strategy life science

Centice (Morrisville, NC) developer of a pharmaceutical verification device to improve accuracy of dispensed medications, closed a $6.1M Series C financing. Participants include Fulcrum Financial Group, The Aurora Funds, S-Group Direct Investments, Innovation Ventures and Novak Biddle Venture Partners.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

Metabolon (Durham, NC) a metabolomics services and informatics company focused on detection of small molecule biomarkers, closed a $6M Series C financing, bringing the entire financing round to $12.3M. Participants include Syngenta Ventures, Fletcher Spaght Ventures, Sevin Rosen Funds, Aurora Funds, Harris and Harris Group, Fulcrum Financial Partners and Alexandria Equities.

NextBio (Cupertino, CA) a commercial-stage bioinformatics and competitive intelligence bioscience search engine, closed a $8M Series C financing. Participants include Newbury Ventures.

HealthHiway (India) a commercial-stage developer of electronic health records software, closed a $4m Series A financing. Participants include Greylock Partners.

Medsphere Systems (Carlsbad, CA) a commercial-stage developer of electronic health records software, closed a $12M Series C financing. Participants include Azure Capital Partners, Epic Ventures, Thomas Weisel Venture Partners and Western Technology Investment.

Humedica (Boston, MA) a development stage bioinformatics company focused on clinical analytics and intelligence, closed a $30M Series A financing. Participants include Bain Capital Ventures, General Catalyst Partners, North Bridge Venture Partners, and Leerink Swann.

DNAnexus (Palo Alto, CA) a development-stage biocomputation company focused on a cloud computing platform infrastructure for the management DNA sequencing data, closed a $1.5M Series A financing. Participants include First Round Capital.

NanoString Technologies (Seattle, WA) a commercial-stage developer of instrumentation and assays for multiplexed detection and quantification of gene expression, closed a $30M Series C financing. Participants include Clarus Ventures, OVP Venture Partners and Draper Fisher Jurvetson.

Zymeworks (Canada) a development-stage computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics, closed a $3.5M Series C financing. Participants include CTI Life Sciences Fund.

GenoLogics (Canada) a commercial-stage bioinformatics company focused on sequencing, genomic and proteomic data management, closed a $4M Series C financing. Participants include OVP Venture Partners, GrowthWorks and Yaletown Venture Partners.

« Previous Entries  

to top of page...